Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Omeros Corporation - Common Stock (NQ:OMER)

14.57 -0.17 (-1.15%)
Streaming Delayed Price Updated: 2:16 PM EDT, Apr 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Omeros Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
News headline image
Omeros Announces Robust Results for Narsoplimab Expanded Access Program in TA-TMA
From Omeros Corporation
Via Business Wire
News headline image
Omeros Corporation Announces Availability on its Website of Materials Accompanying Narsoplimab Presentations at the 2025 Tandem Meetings
From Omeros Corporation
Via Business Wire
News headline image
Omeros Corporation Announces Upcoming Presentations Detailing Outcomes of Narsoplimab Treatment for TA-TMA Under an Expanded Access Program
From Omeros Corporation
Via Business Wire
News headline image
Earnings Scheduled For November 13, 2024 ↗
 
Via Benzinga
News headline image
Earnings Outlook For Omeros ↗
 
Via Benzinga
News headline image
OMER Stock Earnings: Omeros Misses EPS for Q2 2024 ↗
OMER stock results show that Omeros missed analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
News headline image
Omeros Announces Update on Statistical Analysis of Narsoplimab Pivotal Trial Primary Endpoint
From Omeros Corporation
Via Business Wire
News headline image
This Omeros Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Nasdaq Jumps 100 Points, US Initial Jobless Claims Decline ↗
 
Via Benzinga
News headline image
Omeros Antibody Improves Overall Survival In Rare Complication After Stem Cell Transplant, Stock Surges ↗
Omeros announces positive results from a pivotal narsoplimab trial in TA-TMA, showing significant survival benefits and advancing regulatory submissions. 
Via Benzinga
News headline image
Gold Falls Sharply, Lamb Weston Shares Plunge ↗
 
Via Benzinga
News headline image
Accenture Posts Upbeat Results, Joins Darden Restaurants, CarMax And Other Big Stocks Moving Higher On Thursday ↗
 
Via Benzinga
News headline image
Omeros’ Narsoplimab Meets its Pivotal Trial Primary Endpoint – Statistical Analysis Shows Survival Superiority Over External Control in Patients with TA-TMA
From Omeros Corporation
Via Business Wire
News headline image
Omeros Corporation Announces Presentation of Positive Zaltenibart Data at ASH Annual Meeting
From Omeros Corporation
Via Business Wire
News headline image
Jim Cramer Prefers FedEx Over This Delivery Giant That 'Screwed Up A Lot Of Holiday Seasons' ↗
 
Via Benzinga
News headline image
Omeros Corporation Announces Upcoming Presentations at ASH Annual Meeting
From Omeros Corporation
Via Business Wire
News headline image
Natural Grocers By Vitamin Cottage, Elastic, Matthews International, Gap And Other Big Stocks Moving Higher On Friday ↗
 
Via Benzinga
News headline image
Omeros Corporation Provides Update on Progress Toward BLA Resubmission
From Omeros Corporation
Via Business Wire
News headline image
Neurogene, Nvidia And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Omeros Corporation Reports Third Quarter 2024 Financial Results
From Omeros Corporation
Via Business Wire
News headline image
Omeros Corporation to Announce Third Quarter Financial Results on November 13, 2024
From Omeros Corporation
Via Business Wire
News headline image
FDA Grants Rare Pediatric Disease Designation to Omeros’ MASP-3 Inhibitor Zaltenibart for Treatment of C3 Glomerulopathy
From Omeros Corporation
Via Business Wire
News headline image
Omeros Corporation Reports Second Quarter 2024 Financial Results
From Omeros Corporation
Via Business Wire
News headline image
Omeros Corporation to Announce Second Quarter Financial Results on August 7, 2024
From Omeros Corporation
Via Business Wire
News headline image
Omeros Announces Webcast Details for Annual Meeting of Shareholders
From Omeros Corporation
Via Business Wire
News headline image
Omeros Corporation Further Strengthens its Balance Sheet through Series of Financing Transactions Extending Maturity on a Majority of its Outstanding Debt into 2028
From Omeros Corporation
Via Business Wire
News headline image
Crude Oil Moves Higher; Deere Cuts Profit Outlook ↗
 
Via Benzinga
News headline image
Why Fluent Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.